White opaque substance visualized by magnifying narrow-band imaging is associated with intragastric acid conditions
submitted 27 November 2017
accepted after revision 28 March 2018
04 July 2018 (online)
Background and study aims The presence of white opaque substance (WOS) is an endoscopic marker of intestinal metaplasia. Considering that the nature of WOS is absorbed lipid droplets, lipase plays an important role in the lipid absorption process and is inactivated at strong acidity. WOS may only be present in a hypochlorhydria state following Helicobacter pylori infection, and, thus, may not be highly sensitive marker, especially in H. pylori-eradicated patients. We investigated the relationship between WOS and gastric acid conditions.
Patients and methods A total of 501 patients were retrospectively evaluated for the presence of WOS at 2 regions of interest using magnifying narrow-band imaging. The pH level of collected gastric juice was also measured. Study end points were (1) prevalence of WOS and its relationship with gastric juice pH in 3 groups: H. pylori-uninfected, H. pylori-infected, and H. pylori-eradicated; (2) the relationship between prevalence of WOS and gastric juice pH before and after proton pump inhibitor (PPI) administration in 29 H. pylori-eradicated cases.
Results Prevalence of WOS was 0 % (0 /206), 28.4 % (31/109), and 3.2 % (6/186) in the H. pylori-uninfected, H. pylori-infected, and H. pylori-eradicated groups, respectively. Mean gastric juice pH was significantly higher in WOS-positive cases than in WOS-negative cases in the H. pylori-infected and H. pylori-eradicated groups (P < 0.0001). Mean gastric juice pH increased from 1.1 to 6.9 after PPI administration and WOS prevalence increased from 0 % (0/29) to 45 % (13/29) of cases.
Conclusion The prevalence of WOS is closely associated with the neutralization of intragastric pH.
- 1 Uemura N, Okamoto S, Yamamoto S. et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789
- 2 Shichijo S, Hirata Y, Sakitani K. et al. Distribution of intestinal metaplasia as a predictor of gastric cancer development. J Gastroenterol Hepatol 2015; 30: 1260-1264
- 3 Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl 1984; 104: 131-136
- 4 De Vries AC, van Grieken NC, Looman CW. et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-952
- 5 Sugano K, Tack J, Kuipers EJ. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353-1367
- 6 Uedo N, Ishihara R, Iishi H. et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006; 38: 819-824
- 7 Kanemitsu T, Yao K, Nagahama T. et al. Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker. Endoscopy 2017; 49: 529-535
- 8 Yao K, Iwashita A, Tanabe H. et al. White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging: a new optical sign for differentiating between adenoma and carcinoma. Gastrointest Endosc 2008; 68: 574-580
- 9 Yao K, Iwashita A, Nambu M. et al. Nature of white opaque substance in gastric epithelial neoplasia as visualized by magnifying endoscopy with narrow-band imaging. Dig Endosc 2012; 24: 419-425
- 10 Ueo T, Yonemasu H, Yada N. et al. White opaque substance represents an intracytoplasmic accumulation of lipid droplets: immunohistochemical and immunoelectron microscopic investigation of 26 cases. Dig Endosc 2013; 25: 147-155
- 11 Rubin W, Ross LL, Jeffries GH. et al. Some physiologic properties of heterotopic intestinal epithelium. Its role in transporting lipid into the gastric mucosa. Lab Invest 1967; 16: 813-827
- 12 Siurala M, Tarpila S. Absorptive function of intestinal metaplasia of the stomach. Scand J Gastroenterol 1968; 3: 76-79
- 13 Borgstrom B, Brockman HL. Lipases. Amsterdam: Elsevier; 1984
- 14 Chen HN, Wang Z, Li X. et al. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 2016; 19: 166-175
- 15 Ueo T, Yanai Y, Ishida T. [Presence of hematin represents lower intragastric pH level]. Gastroenterol Endosc 2015; 57 : 2054
- 16 Segawa K, Nakazawa S, Tsukamoto Y. et al. Estimate of gastric acid output by evaluation of fasting gastric juice collected endoscopically. Hepatogastroenterology 1991; 38: 79-82
- 17 Fukuta N, Ida K, Kato T. et al. Endoscopic diagnosis of gastric intestinal metaplasia: a prospective multicenter study. Dig Endosc 2013; 25: 526-534
- 18 Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97
- 19 Feldman M, Cryer B, Sammer D. et al. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. Am J Physiol 1999; 277: 1159-1164
- 20 Taguchi Y, Kaito M, Gabazza EC. et al. Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. An ultrastructural study. Scand J Gastroenterol 1997; 32: 656-663
- 21 Kato S, Matsukura N, Matsuda N. et al. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach. J Gastroenterol Hepatol 2008; 23: 258-261
- 22 Iijima K, Sekine H, Koike T. et al. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther 2004; 19: 1181-1188
- 23 Svendsen JH, Dahl C, Svendsen LB. et al. Gastric cancer risk in achlorhydric patients. A long-term follow-up study. Scand J Gastroenterol 1986; 21: 16-20
- 24 Argent RH, Thomas RJ, Aviles-Jimenez F. et al. Toxigenic Helicobacter pylori infection precedes gastric hypochrorhydria in cancer relatives, and H. pylori virulence evolves in these families. Clin Cancer Res 2008; 14: 2227-2235
- 25 Ohtsu K, Yao K, Matsunaga K. et al. Lipid is absorbed in the stomach by epithelial neoplasms (adenomas and early cancers): a novel functional endoscopy technique. Endosc Int Open 2015; 3: E318-E322